Detailed information for compound 986786

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 439.16 | Formula: C13H6Cl2F6N2O2S
  • H donors: 1 H acceptors: 3 LogP: 5.07 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: FC(c1cc(cc(c1)C(F)(F)F)S(=O)(=O)Nc1cc(Cl)nc(c1)Cl)(F)F
  • InChi: 1S/C13H6Cl2F6N2O2S/c14-10-4-8(5-11(15)22-10)23-26(24,25)9-2-6(12(16,17)18)1-7(3-9)13(19,20)21/h1-5H,(H,22,23)
  • InChiKey: RTEXHLWVXGVPBH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.0461 1 1
Echinococcus granulosus glycogen debranching enzyme 0.0128 0.0966 0.0713
Trypanosoma cruzi hypothetical protein, conserved 0.0103 0.0273 0.5
Trichomonas vaginalis glycogen debranching enzyme, putative 0.0128 0.0966 0.3764
Schistosoma mansoni alpha-l-fucosidase 0.0389 0.8036 0.9312
Trichomonas vaginalis alpha-L-fucosidase, putative 0.0171 0.2115 1
Echinococcus multilocularis lysosomal alpha glucosidase 0.0461 1 1
Entamoeba histolytica glycogen debranching enzyme, putative 0.0128 0.0966 1
Echinococcus multilocularis glycogen debranching enzyme 0.0128 0.0966 0.0713
Schistosoma mansoni alpha-glucosidase 0.0411 0.863 1
Trypanosoma brucei glucosidase, putative 0.0103 0.0273 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0103 0.0273 0.5
Echinococcus multilocularis lysosomal alpha glucosidase 0.0461 1 1
Leishmania major alpha glucosidase II subunit, putative 0.0103 0.0273 0.5
Echinococcus multilocularis fucosidase, alpha L 1, tissue 0.0389 0.8036 0.7981
Trichomonas vaginalis glycogen debranching enzyme, putative 0.0128 0.0966 0.3764
Echinococcus granulosus fucosidase alpha L 1 tissue 0.0389 0.8036 0.7981
Toxoplasma gondii Amylo-alpha-1,6-glucosidase 0.0128 0.0966 1
Mycobacterium ulcerans alpha-L-fucosidase 0.0389 0.8036 0.5
Loa Loa (eye worm) hypothetical protein 0.0128 0.0966 0.0713
Brugia malayi Alpha-L-fucosidase family protein 0.0389 0.8036 0.7981
Brugia malayi Amylo-alpha-1,6-glucosidase family protein 0.0128 0.0966 0.0713
Onchocerca volvulus 0.0365 0.7395 0.5
Echinococcus granulosus lysosomal alpha glucosidase 0.0461 1 1
Trichomonas vaginalis alpha-L-fucosidase, putative 0.0171 0.2115 1
Schistosoma mansoni alpha-glucosidase 0.0411 0.863 1
Schistosoma mansoni hypothetical protein 0.0165 0.196 0.2271
Loa Loa (eye worm) alpha-L-fucosidase 0.0389 0.8036 0.7981
Giardia lamblia 4-alpha-glucanotransferase, amylo-alpha-1,6-glucosidase 0.0128 0.0966 0.5
Schistosoma mansoni alpha glucosidase 0.0103 0.0273 0.0316

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.